2024年4月16日 · Many of the new rules Congress is considering in the still-fluid pharmacy benefit management (PBM) legislation would add reporting requirements to meet transparency goals but wouldn’t fundamentally disrupt the industry’s business practices.

2024年11月16日 · The recent round of third-quarter earnings reports by spinal muscular atrophy (SMA) drugmakers provided a snapshot on how these medicines are performing around the world for the year to date and offered insights into how the companies are looking to expand their offerings to untreated patients next year.

2024年11月25日 · CVS Caremark has removed several diabetes drugs favor of newer products and generics, and is even favoring an insulin infusion system developed by a company that was cofounded by Alan Lotvin, a former executive at CVS Health.

2024年7月25日 · Duvyzat was approved in March 2024 and works to reduce the inflammation and loss of muscle experienced by patients with Duchenne muscular dystrophy.

2024年12月20日 · The new, now-defeated bill eliminated the PBM reform measures included in a larger spending bill that the president-elect and Elon Musk torpedoed on Wednesday.

2025年1月7日 · The World Health Organization (WHO) has announced the upcoming development of new lenacapavir and HIV testing guidelines, according to a news release published Monday. Guidelines will be determined during the Guideline Development Group (GDG) meeting, which will be held virtually from Jan. 28-30, 2025.

2024年10月1日 · “We will no longer take part in a pharmacy system that is designed to maximize the profit of participants instead of the quality, convenience and cost-effectiveness for consumers,” Paul Markovich, CEO, Blue Shield of California, said in the news release.. “Every employer, health plan and payer should be asking — and challenging — their pharmacy benefit managers to offer clinically ...

2024年12月23日 · The FDA recently approved Novo Nordisk’s Alhemo (concizumab-mtci), the first subcutaneous, once-daily treatment for hemophilia A or B with inhibitors, designed to prevent or reduce bleeding episodes in patients aged 12 and older.

Managed Healthcare Executive provides C-suite executives at health plans and provider organizations with news, analysis, insights, and strategies to pursue value-driven solutions.

2024年10月9日 · The 2024 increase is the same as last year's increase for family coverage. The foundation’s annual survey of employer health benefits also found that only 18% of large employers (200 employees are more) are covering the GLP-1 weight loss drugs.